Vyvanse generic date?

The “generic date” depends on the country and patent/regulatory status. Here’s a quick summary:

- United States: Vyvanse (lisdexamfetamine dimesylate) had its main patent and exclusivity expire in the early 2020s, and generic lisdexamfetamine dimesylate tablets began appearing in 2023–2024. By 2024–2025 there were multiple generic versions on the market.

- Other countries: Generic timing varies by country based on local patent protections and regulatory approvals.

If you tell me your country (and the dosage you’re asking about), I can give a more precise answer or help you look up the current status (e.g., via the FDA Orange Book or your national regulator). Also, I can help you check which generics are currently available through pharmacies or insurers.